Company Name:Amgen, Inc.
CEO: Robert A. Bradway

Sector: Health Technology
Industry:Biotechnology

Exchange: NASDAQ

Country: US

Description: Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture and marketing of human therapeutics. Its products include the following brands: Aranesp, BLINCYTO, Corlanor, ENBREL, EPOGEN, IMLYGIC, KYPROLIS, Neulasta, NEUPOGEN, Nplate, Parsabiv, Prolia, Repatha, Sensipar, Vectibix, and XGEVA. The company was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.


Key numbers

Market Capitalization:146385265950
Shares Outstanding: 588247000
Float: 586967563
Next Earning Date:2020-11-03
TTm EPS: 12.3169
TTm Dividend Rate: 6.1
200 days moving average:226.71
50 days moving average: 237.97
One day percent Change: -0.6



2018-06-30, 2018-09-30, 2018-12-31, 2019-03-31,
2018-06-30, 2018-09-30, 2018-12-31, 2019-03-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,